Citius Pharmaceuticals, Inc.
CTXR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506251
No open-market purchases or sales by Citius Pharmaceuticals, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $822.4K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Citius Pharmaceuticals, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +4 vs. Q1 2026
- Shares held
- 1.36M
- +362.6K (+36.4%) vs. Q1 2026
- Total value
- $822.4K
- −$74.5K (−8.3%) vs. Q1 2026
- New holders
- 12
- 8 more added
- Sold out
- 8
- 9 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTXR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 42 | $822.4K |
| Q1 2026 | 38 | $896.9K |
| Q4 2025 | 39 | $1.34M |
| Q3 2025 | 34 | $773.4K |
| Q2 2025 | 31 | $1.48M |
| Q1 2025 | 28 | $947.2K |
| Q4 2024 | 30 | $2.43M |
| Q3 2024 | 58 | $11.8M |
| Q2 2024 | 72 | $17.9M |
| Q1 2024 | 73 | $24.6M |
| Q4 2023 | 74 | $20.5M |
| Q3 2023 | 74 | $17.1M |
| Q2 2023 | 75 | $31.0M |
| Q1 2023 | 56 | $16.9M |
| Q4 2022 | 54 | $11.2M |
| Q3 2022 | 57 | $18.9M |
| Q2 2022 | 60 | $14.0M |
| Q1 2022 | 76 | $43.2M |
| Q4 2021 | 77 | $38.1M |
| Q3 2021 | 71 | $51.1M |
| Q2 2021 | 74 | $87.6M |
| Q1 2021 | 39 | $19.3M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Citius Pharmaceuticals, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 215,537 | $130.3K | 0.00% | −30,621−12.4% | Reduced |
| Vanguard Capital Management LLC | 197,364 | $119.4K | 0.00% | +29,626+17.7% | Added |
| Miller Financial Services LLC | 130,000 | $78.6K | 0.06% | +116,000+828.6% | Added |
| Citadel Advisors LLC | 124,910 | $75.5K | 0.00% | +124,910 | New |
| Jane Street Group, LLC | 122,837 | $74.3K | 0.00% | +100,314+445.4% | Added |
| Vanguard Fiduciary Trust Co | 77,755 | $47.0K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 69,850 | $42.2K | 0.00% | −10.0% | Reduced |
| Northern Trust Corp | 62,742 | $37.9K | 0.00% | +18,768+42.7% | Added |
| XTX Topco Ltd | 59,199 | $35.8K | 0.00% | +37,904+178.0% | Added |
| Asset Advisory Group, Inc. | 59,011 | $35.7K | 0.02% | 00.0% | Unchanged |
| BostonPremier Wealth LLC | 28,000 | $16.9K | 0.01% | +28,000 | New |
| UBS Group AG | 26,335 | $15.9K | 0.00% | −28,690−52.1% | Reduced |
| LPL Financial LLC | 25,445 | $15.4K | 0.00% | +400+1.6% | Added |
| State Street Corp | 23,271 | $14.1K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 20,836 | $13.0K | 0.00% | +20,836 | New |
| Arkadios Wealth Advisors | 20,000 | $12.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 17,494 | $10.6K | 0.00% | +4,356+33.2% | Added |
| Sanctuary Advisors, LLC | 11,810 | $7.14K | 0.00% | +11,810 | New |
| Susquehanna International Group, LLP | 11,795 | $7.13K | 0.00% | −25,043−68.0% | Reduced |
| R Squared Ltd | 11,033 | $6.67K | 0.00% | +11,033 | New |
| Two Sigma Securities, LLC | 10,006 | $6.05K | 0.00% | +10,006 | New |
| SBI Securities Co., Ltd. | 9,519 | $5.75K | 0.00% | +3,000+46.0% | Added |
| Chelsea Counsel Co | 4,626 | $2.80K | 0.00% | 00.0% | Unchanged |
| Quent Capital, LLC | 4,232 | $2.56K | 0.00% | −33−0.8% | Reduced |
| IFP Advisors, Inc | 4,183 | $2.53K | 0.00% | −2,900−40.9% | Reduced |
| Tower Research Capital LLC (TRC) | 2,724 | $1.65K | 0.00% | −61−2.2% | Reduced |
| Advisor Group Holdings, Inc. | 2,575 | $1.54K | 0.00% | −160−5.9% | Reduced |
| Group One Trading, L.P. | 1,551 | $938 | 0.00% | +1,551 | New |
| Simplex Trading, LLC | 1,256 | $759 | 0.00% | +1,256 | New |
| Barclays PLC | 1,096 | $663 | 0.00% | +1,096 | New |
| Wells Fargo & Company | 1,000 | $605 | 0.00% | +1,000 | New |
| Luminist Capital LLC | 435 | $263 | 0.00% | +435 | New |
| Assetmark, Inc | 372 | $225 | 0.00% | 00.0% | Unchanged |
| Princeton Global Asset Management LLC | 160 | $97 | 0.00% | 00.0% | Unchanged |
| Smallwood Wealth Investment Management, LLC | 120 | $72 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 120 | $69 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 107 | $65 | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 84 | $51 | 0.00% | +84 | New |
| Federation des caisses Desjardins du Quebec | 80 | $48 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 44 | $27 | 0.00% | −1,320−96.8% | Reduced |
| Fairscale Capital, LLC | 42 | $25 | 0.00% | 00.0% | Unchanged |
| Bogart Wealth, LLC | 4 | $2 | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 0 | $0 | 0.00% | −60,332−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −5,228−100.0% | Sold out |
| Curio Wealth, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −1,788−100.0% | Sold out |
| Ameritas Advisory Services, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Murphy & Mullick Capital Management Corp | 0 | $0 | 0.00% | −160−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −8−100.0% | Sold out |